针对阿片类药物引起的便秘的新兴疗法:我们可以期待什么?
Ghazal Roostaei1,2, Niloofar Khoshnam Rad2,3, Maryam S Fakhri B1
1Department of Internal Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
Expert opinion on pharmacotherapy
|September 23, 2024
概括
阿片类药物诱导的便秘 (OIC) 管理正在发展. 像PAMORA这样的新兴疗法看起来很有前途,但为了获得最佳的患者护理,需要成本和进一步验证.
科学领域:
- 胃肠病学 胃肠病学
- 疼痛管理 疼痛管理
- 药理学 药理学是指药理学的学科.
背景情况:
- 治疗慢性和瘤疼痛的阿片类药物的使用正在增加.
- 阿片类药物引起的便秘 (OIC) 显著影响患者的生活质量和疼痛管理.
- 目前的OIC管理策略需要改进.
研究的目的:
- 审查和批评OIC的新兴疗法.
- 讨论外围作用的片受体对抗剂 (PAMORAs) 和其他新型治疗方法的疗效.
- 突出当前指南的局限性和未来的研究需求.
主要方法:
- 对新兴OIC疗法的批判性审查.
- 对PAMORA的分析 (甲基纳尔特雷克松,纳洛克塞戈尔,纳尔德美丁).
- 包括肠道分泌剂,5-HT受体激动剂和辅助疗法 (TENS,电 ??).
主要成果:
- 帕莫拉有效地针对阿片类药物诱导的肠道功能障碍.
- 其他治疗方法如 lubiprostone, linaclotide 和 prucalopride 提供了替代机制.
- 辅助疗法显示出潜力,但需要进一步验证.
结论:
- 对OIC管理的逐步方法至关重要,考虑到患者因素.
- 帕莫拉显示有效性,但面临成本和比较数据的挑战.
- 未来的研究必须专注于长期成果,成本效益和比较研究.
相关概念视频
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
178
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
178
Drugs for Treatment of Constipation-Predominant IBS
143
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
143
Drugs for Treatment of Diarrhea-Predominant IBS
152
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
152
Opioid Analgesics: Synthetic and Semisynthetic Opioids
246
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
246
Drugs Affecting GI Tract Motility: Other Laxatives
173
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
173
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
188
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
188


